vs
Side-by-side financial comparison of HARVARD BIOSCIENCE INC (HBIO) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
HBIO
TXG
| Q4 25 | $23.7M | — | ||
| Q3 25 | $20.6M | — | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | $21.8M | — | ||
| Q4 24 | $24.6M | — | ||
| Q3 24 | $22.0M | — | ||
| Q2 24 | $23.1M | — | ||
| Q1 24 | $24.5M | — |
Net ProfitHBIOTXG
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-50.3M | — | ||
| Q4 24 | $18.0K | — | ||
| Q3 24 | $-4.8M | — | ||
| Q2 24 | $-2.9M | — | ||
| Q1 24 | $-4.7M | — |
Gross MarginHBIOTXG
| Q4 25 | 59.7% | — | ||
| Q3 25 | 58.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.0% | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 58.1% | — | ||
| Q2 24 | 57.2% | — | ||
| Q1 24 | 60.3% | — |
Operating MarginHBIOTXG
| Q4 25 | 7.2% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | -228.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | -8.5% | — | ||
| Q2 24 | -9.0% | — | ||
| Q1 24 | -9.3% | — |
Net MarginHBIOTXG
| Q4 25 | -12.0% | — | ||
| Q3 25 | -6.0% | — | ||
| Q2 25 | -11.2% | — | ||
| Q1 25 | -231.2% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | -21.9% | — | ||
| Q2 24 | -12.7% | — | ||
| Q1 24 | -19.1% | — |
EPS (diluted)HBIOTXG
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $-1.14 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.11 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.11 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
